OFIX - オ―ソフィックス・インタ―ナショナル (Orthofix Medical Inc. )

OFIXのニュース

   Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 83.2% in October  2020/11/17 16:34:48 Transcript Daily
Orthofix Medical Inc. (NASDAQ:OFIX) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totalling 431,500 shares, a growth of 83.2% from the October 15th total of 235,500 shares. Approximately 2.3% of the shares of the company are sold short. Based on […]
   Orthofix Medical Analyst Valuation and EPS Growth Stock market Insights & financial analysis  2020/10/26 17:25:00 Stock Market Daily
Orthofix Medical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Orthofix Medical (NASDAQ:OFIX) Cut to Hold at BidaskClub  2020/10/25 07:52:46 Zolmax News
Orthofix Medical (NASDAQ:OFIX) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday, BidAskClub reports. A number of other brokerages have also recently commented on OFIX. ValuEngine raised Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Thursday, July […]
   Orthofix Medical (NASDAQ:OFIX) Earns Hold Rating from Analysts at Stifel Nicolaus  2020/10/23 07:06:51 Stock Observer
Stifel Nicolaus initiated coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a report issued on Tuesday, Analyst Ratings Network reports. The brokerage issued a hold rating and a $39.00 price target on the medical device company’s stock. Several other brokerages have also recently issued reports on OFIX. ValuEngine upgraded shares of Orthofix Medical from a […]
   Orthofix Medical (NASDAQ:OFIX) Research Coverage Started at Stifel Nicolaus  2020/10/21 09:36:45 Transcript Daily
Stifel Nicolaus started coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a research note released on Tuesday morning, AR Network reports. The brokerage issued a hold rating and a $39.00 price objective on the medical device company’s stock. Several other research analysts have also recently issued reports on OFIX. ValuEngine raised shares of Orthofix Medical […]
   Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 83.2% in October  2020/11/17 16:34:48 Transcript Daily
Orthofix Medical Inc. (NASDAQ:OFIX) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totalling 431,500 shares, a growth of 83.2% from the October 15th total of 235,500 shares. Approximately 2.3% of the shares of the company are sold short. Based on […]
   Orthofix Medical Analyst Valuation and EPS Growth Stock market Insights & financial analysis  2020/10/26 17:25:00 Stock Market Daily
Orthofix Medical announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   Orthofix Medical (NASDAQ:OFIX) Cut to Hold at BidaskClub  2020/10/25 07:52:46 Zolmax News
Orthofix Medical (NASDAQ:OFIX) was downgraded by BidaskClub from a “buy” rating to a “hold” rating in a note issued to investors on Friday, BidAskClub reports. A number of other brokerages have also recently commented on OFIX. ValuEngine raised Orthofix Medical from a “hold” rating to a “buy” rating in a research report on Thursday, July […]
   Orthofix Medical (NASDAQ:OFIX) Earns Hold Rating from Analysts at Stifel Nicolaus  2020/10/23 07:06:51 Stock Observer
Stifel Nicolaus initiated coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a report issued on Tuesday, Analyst Ratings Network reports. The brokerage issued a hold rating and a $39.00 price target on the medical device company’s stock. Several other brokerages have also recently issued reports on OFIX. ValuEngine upgraded shares of Orthofix Medical from a […]
   Orthofix Medical (NASDAQ:OFIX) Research Coverage Started at Stifel Nicolaus  2020/10/21 09:36:45 Transcript Daily
Stifel Nicolaus started coverage on shares of Orthofix Medical (NASDAQ:OFIX) in a research note released on Tuesday morning, AR Network reports. The brokerage issued a hold rating and a $39.00 price objective on the medical device company’s stock. Several other research analysts have also recently issued reports on OFIX. ValuEngine raised shares of Orthofix Medical […]
   COVID-19: Significant Shift in Strategy of Orthopedic Implants Market 2020-2024 | Rising Prevalence of Orthopedic Conditions to Augment Growth | Technavio  2020/06/25 23:50:00 Benzinga Feeds
Technavio has been monitoring the orthopedic implants market and it is poised to grow by USD 10.09 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200625005787/en/ Technavio has announced its latest market research report titled Global Orthopedic Implants Market 2020-2024 (Graphic: Business Wire). Although the COVID-19 pandemic continues to transform the growth of various industries, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. Technavio's in-depth research has all your needs covered as our research reports include all foreseeable market scenarios, including pre- & post-COVID-19 analysis.
   Orthofix Announces Sponsorship of Olympic Gold Medalist and Spine Patient Laura Wilkinson  2020/05/26 12:00:00 Business Wire
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc., a global medical device company, today announced its sponsorship of Olympic Gold Medalist and Spine Patient Laura Wilkinson.
   The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study  2020/03/06 13:49:43 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Centogene NV (NASDAQ: CNTG ) Cue Biopharma Inc (NASDAQ: CUE ) Forty Seven Inc (NASDAQ: FTSV ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Molecular Templates Inc (NASDAQ: MTEM ) Natera Inc (NASDAQ: NTRA ) Ocular Therapeutix Inc (NASDAQ: OCUL ) (Piper Sandler lifted the price target for the shares from $7 to $11) Quest Diagnostics Inc (NYSE: DGX ) (announced plans to launch a COVID-19 test service) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Zynex Inc. (NASDAQ: ZYXI ) Down In The Dumps (Biotech stocks that hit 52-week lows March 5.) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) AngioDynamics, Inc. (NASDAQ: ANGO ) ANI Pharmaceuticals Inc Common Stock (NASDAQ: ANIP ) Aytu Bioscience Inc (NASDAQ: AYTU ) Celcuity Inc (NASDAQ: CELC ) Chembio Diagnostics Inc (NASDAQ: CEMI ) Eagle Pharmaceuticals Inc (NASDAQ: EGRX ) Eiger Biopharmaceuticals Inc (NASDAQ: EIGR ) Enlivex Therapeutics Ltd (NASDAQ: ENLV ) Evogene Ltd (NASDAQ: EVGN ) EXACT Sciences Corporation (NASDAQ: EXAS ) Glaukos Corp (NYSE: GKOS ) Lantheus Holdings Inc (NASDAQ: LNTH ) Mylan NV (NASDAQ: MYL ) Neurometrix Inc (NASDAQ: NURO ) Organogenesis Holdings Inc (NASDAQ: ORGO ) Orthofix Medical Inc (NASDAQ: OFIX ) Passage Bio Inc (NASDAQ: PASG ) (went public last week) Polarityte Inc (NASDAQ: PTE ) STRATA Skin Sciences Inc (NASDAQ: SSKN ) SurModics, Inc. (NASDAQ: SRDX ) (reacted to first-quarter results) T2 Biosystems Inc (NASDAQ: TTOO ) Xeris …
   The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19  2020/03/05 13:05:44 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) 89bio Inc (NASDAQ: ETNB ) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Therapeutics Ltd (NASDAQ: ARCT )(announced a partnership with Duke-NUS Medical School to develop a COVID-19 vaccine for Singapore) Cue Biopharma Inc (NASDAQ: CUE ) IGM Biosciences Inc (NASDAQ: IGMS ) Inovio Pharmaceuticals Inc (NASDAQ: INO ) Ocular Therapeutix Inc (NASDAQ: OCUL )(reacted to its preliminary fourth-quarter results and interim data from a Phase 1 study evaluating its eye implant OTX-TKI in patients with wet age-related macular degeneration) Quest Diagnostics Inc (NYSE: DGX ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN )(CEO Leonard Schleifer reportedly told CNBC the company hopes to produce COVID-19 treatment candidate that could be ready for human testing by August) Revolution Medicines Inc (NASDAQ: RVMD ) (IPOed mid-February) SpringWorks Therapeutics Inc (NASDAQ: SWTX ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX )(reacted to the company's fourth-quarter results) Syneos Health Inc (NASDAQ: SYNH ) Viela Bio Inc (NASDAQ: VIE ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on March 4) Alterity Therapeutics Ltd (NASDAQ: ATHE ) AngioDynamics, Inc.
   Orthofix Supports FDA Class III Label Continuation for BGS  2020/02/28 06:53:00 Zacks Investment Research
Orthofix (OFIX) pledges support for the continuation of the FDA's Class III status of BGS devices.

calendar